FindTrial
Sign In

The effect of Yufengningxin drop pill on blood pressure and microcirculation in patients with essential hypertension: a prospective cohort study

The effect of Yufengningxin drop pill on blood pressure and microcirculation in patients with essential hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16008360
Enrollment
Unknown
Registered
2016-04-28
Start date
2016-04-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

treatment group:Yufengningxin drop pill+standard therapy
control group:standard therapy

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with identified hypertension; (2) Aged 18-75 years old; (3) Patients providing written informed consents.

Exclusion criteria

Exclusion criteria: (1) Patients with poor control of blood pressure (systolic pressure>=160mmHg, or diastolic pressure >=100mmHg), or with secondary hypertension; (2) Patients with diabetes mellitus; (3) Patients have a history of cardiovascular and cerebrovascular diseases; (4) Patients with a history of serious hepatic, renal, hematological, neurological, or severe psychiatric diseases; (5) Patients with malignant tumors; (6) Patients who have participated in other clinical trials within 3 months; (7) Women with pregnancy, planned pregnancy; patients are allergic to the components of the experimental drugs.

Design outcomes

Primary

MeasureTime frame
blood pressure;—

Secondary

MeasureTime frame
microcirculation;levels of blood lipid;—

Countries

China

Contacts

Public ContactXiuhua Liu

Chinese PLA General Hospital

liuxiuhua98@163.com+86 010-66939763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026